Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-024469
Filing Date
2020-05-12
Accepted
2020-05-12 06:06:31
Documents
68
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q surf-10q_20200331.htm 10-Q 1562160
2 EX-31.1 surf-ex311_7.htm EX-31.1 17922
3 EX-31.2 surf-ex312_9.htm EX-31.2 17930
4 EX-32.1 surf-ex321_8.htm EX-32.1 7045
5 EX-32.2 surf-ex322_6.htm EX-32.2 7061
  Complete submission text file 0001564590-20-024469.txt   6585068

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT surf-20200331.xml EX-101.INS 1430972
7 XBRL TAXONOMY EXTENSION SCHEMA surf-20200331.xsd EX-101.SCH 49068
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE surf-20200331_cal.xml EX-101.CAL 50728
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE surf-20200331_def.xml EX-101.DEF 200377
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE surf-20200331_lab.xml EX-101.LAB 446023
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE surf-20200331_pre.xml EX-101.PRE 345783
Mailing Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139 617-714-4096
Surface Oncology, Inc. (Filer) CIK: 0001718108 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38459 | Film No.: 20866955
SIC: 2836 Biological Products, (No Diagnostic Substances)